seroconversion

Study Finds Both Covaxin, Covishield Good – but Issues Mar Other Results

How ICMR and Others Spun Covaxin’s Phase 1 Trial Results Out of Context

COVID-19: ICMR’s Rush to Produce ‘Indian Vaccine’ Suggests Politics is Driving Science